 Avril Lee |
Burson-Marsteller has named Avril Lee deputy global healthcare practice chair. Stationed in London, the former managing director of MSL Group's UK & EMEA health unit, will join the WPP unit Feb. 19. Helene Ellison is B-M's global healthcar practice chair.
During a two-year stint at Publicis Groupe's MSL, Lee was responsible for the global effort of Allergan's ophthalmology and medical asethetics businesses and other clients in the biopharma, device and diagnostics and O-T-C segments.
Earlier, she was with Luther Pendragon as director for its AbbVie Humira business and Ketchum London serving as relationship lead for Bayer Global & Roche.
B-M CEO Don Baer called strengthening London healthcare capabilities central to the firm's global ambitions.
Lee will report to Ellison and Stephen Day, CEO, B-M London.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
